Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
In the main bearcast of the day I start by asking what payoff disgraced Dave Whitby got at worthless insolvent POS Andalas (ADL)? And were mugs who backed the latest placing told where much of their cash was going ( i.e. to Whitby). Feel free to contact me if you are an Andalas owning mug. The fat Lady arrives at Nighthawk (HAWK) and looks to be in the wings at Nature Group (NGR) while new problems emerge at Imaginatik (IMTK) - a former Rob Terry fave but I speculate on bigger worries that the Quindell fraudster faces - and at Management Consulting (MMC). I think the fat Lady may well also have an appointment with Widecells Group ( WDC) shortly. I comment on 4 reasons why Advanced Oncotherapy (AVO) shares may be falling and on looming results at Optibiotix (OPTI), where we own shares.
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.